الفهرس 
THE VEINS OF THE UPPER EXTREMITYOnly 14 pages are availabe for public view
 |  | from | 111 |  |  |
| | | from | 111 | | |
Abstract
Vascular access is the life line for patients on hemodialysis. Most surgeons advocate the native arteriovenous fistula (AVF) to be the preferred vascular access due to longer patency and less complications.
The National Kidney Foundation Dialysis Outcome Quality Initiative (NKF-DOQI) recommends autologous radio-cephalic or brachiocephalic AVF as a primary method of choice in HD patients, but for the patients with failed radio-cephalic fistula (RCF) or brachiocephalic fistula (BCF) or with smaller caliber superficial veins, vascular access becomes difficult. Therefore, the basilic vein AVF as a secondary option is recommended in those patients.
This study is a prospective non randomized clinical study conducted at Ain Shams University Hospitals on 50 patients with ESRD on regular dialysis recruited for brachio-basilic AVF in the period from March 2020 to November 2020. Follow up was done for 18 months till May 2022, and aimed to compare outcomes for techniques in the second stage brachiobasilic arteriovenous fistula, basilic vein transposition or basilic vein superficialization, to determine primary, assisted primary and secondary patency of each technique and any procedure related complications.
We found that there’s no statistically significant difference between the two groups for primary, assisted primary or secondary patency rates.
We also found that Hypertension was associated with decreased primary patency at 18 months with p-value of 0.0163 and Ischemic heart disease was associated with decreased primary patency at 6 and 12 months with p-value of 0.0204 and 0.0168 respectively.
Surprisingly, we found that some risk factors as diabetes did not affect patency. Some anatomical factors could not be well studied due to study limitations as small sample size.